Familial Chylomicronemia Syndrome (FCS)

DBCOND0055881Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesLipids

Familial Chylomicronemia Syndrome (FCS) is the indication for 3 drugs in DrugBank. It is covered by 3 curated, structured indications.

Also known as
Chylomicronemia, Familial · Familial Chylomicronemia Syndrome · Familial Chylomicronemia
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHT812595ICD-10E78.1SNOMED CT1197489003MedDRA10017347UMLSC0020480

What you can answer from here — as of October 25, 2026

3Indicated drugsWith each drug's targets and mechanism
Listed above
3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
18Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Familial Chylomicronemia Syndrome (FCS) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In